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In vitro translationIncorporation of selenocysteine (Sec) in bacteria requires a UGA codon that is reassigned to Sec by
the Sec-speciﬁc elongation factor SelB and a conserved mRNA motif (SECIS element). These
requirements severely restrict the engineering of selenoproteins. Earlier, a synthetic tRNASec was
reported that allowed canonical Sec incorporation by EF-Tu; however, serine misincorporation
limited its scope. We report a superior tRNASec variant (tRNAUTuX) that facilitates EF-Tu dependent
stoichiometric Sec insertion in response to UAG both in vivo in Escherichia coli and in vitro in a
cellfree protein synthesis system. We also demonstrate recoding of several sense codons in a SelB
supplemented cell-free system. These advances in Sec incorporation will aid rational design and
directed evolution of selenoproteins.
 2015 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Organisms pay a high ﬁtness cost for the beneﬁt of endowing
proteins with the unique properties of the 21st amino acid, seleno-
cysteine (Sec) [1,2], and have evolved complex biosynthetic and
translational mechanisms to incorporate Sec [3,4]. At the interface
of Sec synthesis and insertion lies tRNASec. Initially acylated by
seryl-tRNA synthetase (SerRS) to form Ser-tRNASec, the bacterial
enzyme SelA catalyzes the conversion of Ser to Sec in a single step
on the tRNA [3]. Once synthesized, selenocysteinyl-tRNA
(Sec-tRNASec) is bound by the specialized Sec-speciﬁc elongation
factor SelB, which subsequently binds to a highly conserved
mRNA motif denoted as Selenocysteine Insertion Sequence
(SECIS), facilitating insertion of Sec at a UGA codon [3]. In bacteria,the SECIS sequence is located directly after the suppressed UGA
and is thus part of the coding sequence of bacterial genes, making
engineering of newly designed selenoproteins very difﬁcult [5–7].
Recently, we reported construction of a synthetic tRNA (tRNAUTu)
that enabled SECIS-independent and EF-Tu-dependent insertion
of Sec in Escherichia coli [8]. This tRNAUTu combines the aminoacyl
acceptor helix of tRNASec with the backbone of tRNASer, and serves
as a substrate for the essential proteins SerRS, SelA, and EF-Tu. By
virtue of its interaction with EF-Tu, Sec-tRNAUTu circumvents the
need for the Sec-speciﬁc elongation factor SelB, and more impor-
tantly does not require the SECIS mRNA motif. Sec-tRNAUTu there-
fore participates in canonical translation, allowing versatile
sequence-independent production of designed selenoproteins pro-
grammed by UAG.
While SelB recognizes only Sec-tRNASec [9,10], EF-Tu serves all
other aminoacyl-tRNAs (aa-tRNAs). Therefore, if the
SelA-dependent conversion of Ser-tRNAUTu to Sec-tRNAUTu is not
complete, Ser will be incorporated instead of the desired Sec resi-
due. This was an impediment in the earlier work in which 30%
misincorporation of Ser was observed [8]. We reasoned that by
designing an improved tRNAUTu with better substrate properties
for SelA, misincorporation could be prevented. Here we report such
a tRNA (tRNAUTuX) that allows complete Sec incorporation in vivo
and in vitro in response to UAG.
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2.1. In vitro Sec-tRNA formation
To characterize in vitro formation of Sec-tRNA, tRNA species
were radiolabeled using [a-32P]ATP and the E. coli CCA editing
enzyme [11]. Ser-tRNA formation by SerRS, selenophosphate pro-
duction by SelD, and Ser to Sec conversion by SelA was carried
out under anoxic conditions as previously described [8].
Conversion rates were determined by autoradiography and by
quantitation of aminoacyl-AMP after thin layer chromatography
of nuclease P1 digests of aminoacyl-tRNAUTu [12]. For use in cell
free protein synthesis experiments, Sec-tRNA was phenol–chloro-
form extracted, ethanol precipitated, and resuspended in RNase
free H2O to desired concentration.Fig. 1. (A) Secondary structure of tRNAUTuX. Nucleotides that were changed from the orig
tRNAUTuX mediates functional Sec insertion in FDHH. An E. coli DselA DselB DfdhF triple
alongside tRNASecop , E. coli SelB, and WT FDHH140op; tRNAUTuam and FDHH140am; tRNAUTuX am a
activity was assessed by appearance of the purple-colored reduced BV. (C) In vitro conv
incubated with 5 mM SelD, 1 mM Na2SeO3 and 5 mM ATP at pH 7.2 under anaerobic condit
radiolabeled Ser-tRNA species for up to 20 min. Aliquots of 1.5 lL were taken at the ind
chromatography plates. After developing, plates were analyzed by autoradiography. While
nearly full conversion to Sec-tRNA over a course of 20 min.2.2. In vivo tRNAUTu utilization assay
E. coli DselA DselB DfdhF strain MH5 was co-transformed with
plasmids pACYC-[E. coli selA+, M. jannaschii pstk] and
pGFIB-[tRNAUTuam ], or pGFIB-[tRNAUTuXam ] variants as well as
pRSF-[E. coli serS-fdhF140am] and grown on LB medium supplemented
with the corresponding antibiotics ampicillin, chloramphenicol, or
kanamycin. As a control E. coliMH5was co-transformedwith the plas-
mids pACYC-[E. coli selA+, M. jannaschii pstk], pRSF-[E. coli
serS-fdhF140op] and pET15b-[E. coli selB] to reconstitute the wild-type
(WT) Sec formation apparatus using the genomically encoded
tRNASec. E. coli MH5 carrying plasmids pACYC-[E. coli selA+ M. jan-
naschii pstk], pRSF-[E. coli serS-fdhF140am] and pET15b-[E. coli selB]
served as a second control. Overnight cultures of these clones were
plated on LB agar plates supplemented with 10 lM IPTG, 1 lM
Na2MoO4, 1 lM Na2SeO3 and 50 mM sodium formate, as previouslyinal tRNAUTu are highlighted in red and the amber anticodon is depicted in green. (B)
deletion strain was separately complemented with E. coli SelA, M. jannaschii PSTK
nd FDHH140am; and a negative control with tRNASecop, E. coli SelB, and FDHH140am. FDHH
ersion of Ser-tRNASec, Ser-tRNAUTu, and Ser-tRNAUTuX by SelA. Reactions were pre-
ions at 37 C for 30 min and then supplemented with 1 lM SelA and 10 lM of [a32-P]
icated time points, digested with nuclease P1, and spotted onto cellulose thin layer
approximately 50% of Ser-tRNAUTu was converted, both tRNASec and tRNAUTuX support
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Plates were then overlaid with a top agar containing 1 mg/mL benzyl
viologen (BV), 250 mM sodium formate, and 25 mM KH2PO4 pH 7.0.
The appearance of a purple color indicated catalytically active FDHH,
which depends on Sec insertion at position 140.
2.3. Cell-free selenoprotein synthesis
Cell-free in vitro translation experiments were conducted using
the PURExpress in vitro Protein Synthesis Kit (E6800S) or
PURExpress DRF123 kit (E6850S, New England Biolabs Inc.), as
noted. Reactions were prepared according to the manufacturer’s
instructions inside an anaerobic chamber, and were supplemented
with 1 lM sodium molybdate, 40U RNasin Plus RNase Inhibitor
(Promega), and 250 ng of fdhF mutants at position 140 cloned into
PURE vector. Reactions were normalized against expressed dihy-
drofolate reductase (DHFR) as a negative control, a protein that
did not exhibit measureable reduction of BV.
For translation mediated by tRNASecam, tRNASecop , tRNASecCGU, tRNASecGCC,
tRNASecCCU, and tRNASecUCG, PURExpress kit reactions were supplemented
with 12 lM Sec-tRNASelCam , 12 lM SelB, and were allowed to proceed
for two hr at 37 C. For expression mediated by tRNAUTuam , tRNAUTuXam ,
or tRNASecUXam , PURExpressDRF123 kit reactions were prepared in
the absence of RF1, supplemented with 70 lM Sec-tRNA, 67 lM
EF-Tu, and were allowed to proceed for ﬁve hr at 37 C. Plasmid
containing fdhF with corresponding cognate codon at position 140
was also added to each reaction. Following protein synthesis,Fig. 2. Activity of rationally designed tRNAUTu variants. For each of the sixteen variants s
shown in the upper left. Each variant as well as E. coli SelB and SelA was used to complem
by appearance of the purple colored reduced BV, with the activity mediated by each va0.7 mg/mL BV and 7 mM sodium formate were added to the reaction
mixture to a ﬁnal volume of 30 lL. FDHH activity was monitored
over time via absorbance at 578 nm measuring using a Nanodrop
2000 (Thermo-Scientiﬁc NanoDrop 2000 UV–vis Spectrophotometer).
As a negative control, a reaction was prepared with 12 lM
Ser-tRNASecam instead of Sec-tRNASecam; absence of BV reduction activity
was conﬁrmed following this reaction.
3. Results
The co-crystal structure of decameric Aquifex aeolicus SelA pro-
tein in complex with ten Thermus tengcongensis tRNASec molecules
provided molecular insight into the enzyme’s substrate recognition
and coordination, illustrating the mechanism by which SelA dis-
criminates between tRNASer and tRNASec [15]. This information
was used to rationally engineer additional tRNAUTu variants to
act as ideal substrates for SelA that would increase the yield of
Sec conversion and ﬁnally insertion.
Using site-directed mutagenesis, we incrementally changed the
sequence of the original tRNAUTu to more closely resemble the fea-
tures of tRNASec that contribute to binding of SelA.
These modiﬁcations comprised both single and combined
exchanges as well as insertions and deletions of nucleotides in var-
ious regions of the tRNA. However, they left the critical tRNAUTu fea-
tures that (i) provide thermodynamic binding speciﬁcity for EF-Tu
[16] and (ii) contribute to the incompatibility between tRNASec
and EF-Tu [17] (Fig. 1A). A total of 29 tRNA variants were producedhown, mutations relative to tRNAUTu are depicted in green, with the original variant
ent FDHH140am in strain MH5 E. coli (DselA DselB DfdhF). FDHH activity was assessed
riant shown adjacent to it.
Fig. 3. Assessment of tRNAUTuX-mediated Sec insertion ﬁdelity. (A) Sec-dependent
in vitro BV reduction of recombinant puriﬁed FDHH variants. 100nM each of WT
FDHH140op and FDHH140am produced with tRNAUTu and tRNAUTuX were assayed in the
linear range of the reaction for 5 min. Relative speciﬁc activity of FDHH variants
expressed using tRNASecop , tRNAUTu, or tRNAUTuX were determined. Compared to WT
tRNASecop , synthetic variants tRNAUTuX and tRNAUTu mediated Sec insertion into
FDHH140am allowed 98.5 ± 15.8% and 71.1 ± 17.0% BV reduction activity, respectively.
(B) Sec incorporation into recombinant E. coli Grx1 variants as determined spectro-
metrically by assaying DTNB (Ellman’s reagent) binding. Relative to WT tRNASecop ,
expression of Grx1C11am with tRNAUTuX and tRNAUTu resulted in 99.2 ± 8.4% and
71.2 ± 7.1% DTNB coupling, respectively. (C) Fourier transform ion cyclotron reso-
nance (FT-ICR) mass spectrometry of puriﬁed Grx1C11am. Mass peaks of 11018.33 and
11040.31m/z were observed, corresponding to the masses of a Grx1C11U glutathione
adduct (11019.38), and a glutathione plus Na+ adduct (11041.34). The unit m/z
describes the mass-to-charge ratio.
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insertion, using E. coli FDHH as a reporter protein (Fig. 2). A natural
selenoenzyme, FDHH contains an essential Sec residue at position
140, and catalyzes the electron transfer from formate onto theartiﬁcial electron acceptor benzyl viologen under anaerobic condi-
tions. We used the FDHH-mediated BV reduction as a sensitive
colorimetric in vivo reporter system for functional Sec insertion,
as reduced BV adopts a dark purple color [18] (Fig. 1B).
Consequently, the E. coli DselA DselB DfdhF triple deletion strain
MH5 was complemented with a vector encoding SelA, PSTK,
FDHH140am and each tRNAUTuam variant, subsequently grown in the
presence of formate and BV [8]. To serve as a positive control,
FDHH140op expressed with the genomic WT tRNASecop was also grown
in the presence of SelB (Fig. 1B). Using this cell based assay, a tRNA
variant capable of producing active FDHH with the same apparent
BV reduction activity as the WT was identiﬁed from among the 29
tRNAUTu variants (Figs. 1B and 2), notably producing visibly more
reduced BV than the original synthetic variant. This improved tRNA
was named tRNAUTuXam ; it differs from the original tRNAUTu in 11 posi-
tions (Figs. 1A, 2 and S1). To validate the observed BV color formation,
tRNAUTuXam was then characterized in a set of in vitro experiments.
While the modiﬁcations introduced in tRNAUTuX focused on
better interaction with SelA, it was a prerequisite to retain robust
Ser-tRNAUTuX formation by SerRS. Serylation assays of tRNAUTuX,
tRNASec, and the original tRNAUTu did not reveal any signiﬁcant
differences among the three tRNA species (Table S1), as the KM
(3.5 lM), kcat (0.42 min1), and kcat/KM (0.12 lM1 min1) of
tRNAUTuX were found to be very close to those of tRNASec and
tRNAUTu. Subsequently, conversion of Ser-tRNAUTuX to Sec-tRNA
by SelA was examined (Fig. 1C). In contrast to the original
tRNAUTu, which showed about 50% SelA-dependent conversion
to Sec-tRNA, Ser-tRNAUTuX and WT Ser-tRNASec were very similar
and yielded 90% Sec formation (after 20 min). Tighter binding
of Ser-tRNAUTuX to SelA was further conﬁrmed by RNase protection
in the presence of excess SelA protein, revealing that within 20 min
twice the amount of Ser-tRNAUTu was digested by nuclease P1 than
Ser-tRNAUTuX or Ser-tRNASec (Fig. S2).
To determine the yield of Sec insertion by tRNAUTuX we next
measured the speciﬁc activity of puriﬁed FDHH following
expression in vivo. Using FDHH140op produced by WT tRNASec as a
standard, the speciﬁc activity of FDHH140am synthesized in the
presence of either tRNAUTuXam or tRNAUTuam was measured for
comparison. FDHH made with tRNAUTuam had 70% of the speciﬁc
activity of the enzyme made with WT tRNASec, and tRNAUTuXam pro-
duced an enzyme with activity equivalent to the WT (Fig. 3A).
A similar analysis was then performed using the small E. coli
redox protein glutaredoxin, Grx1, which contains two Cys residues
(positions 11 and 14). These residues were mutated to
amber11/Ser14 and Cys11/Ser14 to generate Grx1 variants con-
taining a single Cys or Sec residue at position 11 [8].
Grx1amber11/Ser14 was then expressed in vivo in the presence of
either tRNAUTuXam or tRNAUTuam and puriﬁed while Grx1Cys11/Ser14 served
as a control. DTNB [5,50-dithiobis-(2-nitrobenzoic acid)] reacts with
Cys and Sec residues, while it has no afﬁnity for Ser [19]. This results
in a visible color change, which can be quantiﬁed spectroscopically.
This reaction was used to determine the Sec insertion ratio in corre-
lation to Grx1Cys11/Ser14. In agreement with the results obtained for
FDHH (Fig. 3A), DTNB treatment of the Grx1amber11/Ser14 gene product
synthesized with tRNAUTuXam gave the same colorimetric signal inten-
sity as Grx1Cys11/Ser14; this indicated stoichiometric Sec insertion. In
contrast, the Grx1amber11/Ser14 gene product made by the original
tRNAUTuam [8] had a weaker signal, exhibiting only 70% of the WT
intensity. This is in line with the earlier ﬁnding of 30% misincorpora-
tion of Ser [8] (Fig. 3B). These results were conﬁrmed by intact
mass FT-ICR mass spectrometry (Fig. 3C). Peaks at masses of
11018.33 and 11040.31 Da were observed, which correspond to
the calculated masses for a Grx1-Sec11-GSH (11019.43) and a
Grx1-Sec11-GSH/Na+ adduct (11040.39), respectively. No mass
peaks that coincide with a Grx1-Ser11 species were detected.
Fig. 4. Activity of FDHH produced through cell-free protein synthesis. Cell-free
translation of selenoprotein FDHH was mediated by different Sec-tRNA variants and
cognate fdhF140 mutants under optimized conditions (see Section 2), and FDHH140am
activity was monitored through reduction of BV at 578 nm. (A) Activity of tRNAUTuam ,
tRNAUTuXam , and tRNASecUXam -mediated FDHH140am translation in the absence of release
factor 1 (while in the presence of RF2 and RF3) was found to be comparable for each
variant. (B) Translation of FDHH mutants with cognate tRNA variants tRNASecam, tRNASecop ,
tRNASecCGU, tRNASecGCC, tRNASecCCU, and tRNASecUCG in the presence of SelB demonstrates that
each sense codon is capable of recoding with selenocysteine in vitro. Absence of
activity was conﬁrmed in a negative control reaction prepared with Ser-tRNASecam in
place of Sec-tRNASecam, and in a separate negative control prepared with plasmid
encoding dihydrofolate reductase (DHFR) in place of fdhFam.
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in synthesizing proteins containing non-standard amino acids
[20,21]. Sec insertion has also been observed in eukaryotic cell
free systems [22,23], detected as read-though products of a
luciferase reporter protein. We sought to test the capacity of
tRNASec and the synthetic tRNAUTu to synthesize a natural
selenoenzyme by in vitro translation. For this we used the
PURExpress in vitro translation system (NEB). To achieve Sec
insertion, Sec-tRNASecam was prepared biochemically and added to
the reaction. However, as Sec-tRNASec must compete with canonical
tRNA for EF-Tu binding, we anticipated a large quantity would be
required to mediate translation. Additionally, while translation of
E. coli FDHH enabled sensitive colorimetric detection of Sec inser-
tion, the large size of the protein and presence of both molybde-
num and iron-sulfur cofactors meant an extended elongation time
would likely be required.
Translation reactions were run under anoxic conditions, using a
plasmid containing the fdhF140am gene under a T7 promoter to
facilitate transcription of FDHH140am mRNA. To eliminate competi-
tion for the UAG140 codon, the translation system lacked release
factor 1 (PURExpressDRF123 kit, NEB) while including RF2 and
RF3, and was supplemented with sodium molybdate, RNase
inhibitor, and elongation factor SelB. Using Sec-tRNASecam, activeFDHH was successfully produced after the standard 2 h reaction
time, yet these conditions produced active selenoenzyme only with
wild-type Sec-tRNASec. However, in the absence of SelB but with the
addition of an excess of EF-Tu, elevated levels of Sec-tRNA, and a
long (5 h) incubation time, all three synthetic tRNA variants
(tRNAUTuam , tRNAUTuXam , and the recently reported tRNASecUXam [24]) were
found to give active FDHH protein (Fig. 4A). Using the speciﬁc activity
calculated for WT FDHH, the in vitro yield of active protein under the
respective optimal conditions for each tRNA was roughly 34.7 ng
using tRNASecam, 47.1 ng using tRNASecUX, 78.7 ng using tRNAUTu, and
83.6 ng using tRNAUTuX. Thus, each synthetic tRNA produced FDHH
activity similar to both one another and WT tRNASec.
Although selenocysteine is encoded by UGA in nature, we have
previously shown that many E. coli codons can be reassigned to Sec
if the WT UGA codon preceding the SECIS element is replaced by a
sense codon [10]. Using our cell-free selenoprotein synthesis sys-
tem, we investigated the capacity to in vitro recode sense codons
in FDHH to Sec. Mutant genes encoding fdhF140GGC, fdhF140CGA,
fdhF140AGG, fdhF140ACG, and WT fdhF140op were paired with their
respective cognate tRNASec mutants, and expressed in vitro in the
presence of SelB. While several of these codons did not produce
active FDHH in vivo, all variants tested were found to yield active
enzyme in vitro (Fig. 4B) with estimated yields of 5.3 ng using
tRNASecGCC (fdhF140GGC), 10.9 ng using tRNASecUCG (fdhF140CGA), 18.4 ng
using tRNASecCCU (fdhF140AGG), 2.6 ng using tRNASecCGU (fdhF140ACG)
and 12.8 ng using WT tRNASecop (fdhF140op).
In light of the in vitro recoding capacity of codons AGG and CGA,
we reinvestigated the activity of these fdhF variants in vivo.
Translation of fdhF140AGG and fdhF140CGA mRNA, isolation of
FDHH, and determination of speciﬁc activity showed recoding
levels of AGG and CGA to be 65% and 46%, respectively. These
results are incorporated in the data shown in Fig. S3.
4. Discussion
The major improvement of tRNAUTuX over tRNAUTu is seen in its
ability to be an almost WT tRNASec-like substrate for SelA ensuring
optimal Ser to Sec conversion (Fig. S2). At the same time, tRNAUTuX
is a better SerRS substrate than tRNASec (Table S1). These proper-
ties make tRNAUTuX our best tRNAUTu molecule for selenoprotein
production.
Based on similar criteria for elongation and release factor recog-
nition/rejection a different tRNA molecule for canonical Sec inser-
tion was recently selected [24]. As its design began with the WT
tRNASec scaffold, tRNASecUX and tRNAUTuX are of different sequence
in the D-arm, anticodon stem, variable arm, and T-arm; however,
the two tRNAs contain the same critical structural parameters for
EF-Tu binding [17]. This demonstrates that similar recognition
and biological properties can be achieved by different nucleic acid
landscapes.
While cell free synthesis of selenoproteins has previously been
reported in partially puriﬁed components of the eukaryotic path-
way (including puriﬁed Sec-tRNASec) [22], we established an
in vitro translation system for selenoproteins using commercially
available bacterial components. Since protein synthesis quality
controls for EF-Tu and SelB are relaxed in this PURExpress transla-
tion system, it was foreseen that protein yields would be low. Yet
the availability of a sensitive color assay (benzyl-viologen reduc-
tion [18]) encouraged us to synthesize FDHH, a selenoprotein
whose enzyme activity depends on the presence of Sec, an iron sul-
fur cluster, and molybdenum as cofactor. Our strategy was success-
ful; now the task at hand is to optimize protein production.
Addition or co-expression of SelA and SelD (and selenite) may
increase Sec-tRNAUTuX yield leading to additional rounds of protein
synthesis. In view of the extensive efforts to optimize bacterial
C. Miller et al. / FEBS Letters 589 (2015) 2194–2199 2199cell-free expression systems [25] and the success of generating suf-
ﬁcient Sec-tRNA in vitro, we anticipate this approach to lead to the
in vitro generation of additional selenoproteins in the future.
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